Poster Number | Abstract Title |
1 | A rare case of an IgM warm autoantibody causing autoimmune hemolytic anemia (AIHA) |
2 | Platelet transfusions in the extreme: a review of the literature |
3 | First home blood transfusion in a pediatric patient in Quebec |
4 | Intravenous albumin in Cardiac and Vascular surgery: A Systematic Review and Meta-analysis |
5 | RHD Genotyping for Selected Perinatal People to Reduce RhIG Administration |
6 | Estimation of Fetal Maternal Hemorrhage by Keilhauer Betke and Flow Cytometry |
7 | Differentiation of passive and alloimmune anti-D using an enzyme indirect antiglobulin test |
8 | Red Blood Cell Transfusion Practice Pattern Before and After Implementation of a Local Restrictive Transfusion Protocol in a Neonatal Intensive Care Unit |
9 | Isohemagglutinin Titration: Donor versus component testing to identify low titre platelets. |
10 | Alloimmunization following transfusion of DEL donor red blood cells: Two cases with different immunological responses |
11 | Optimizing Enzyme Enhancement for the Serologic Investigation of Rhesus Antibodies |
12 | Non-Invasive Perinatal Testing for fetal RHD: Preparing for Test Implementation |
13 | Implementation of sexual risk-based criteria: impact on safety and adequacy of supply |
14 | Implementation of an enhanced donor question regarding ethnicity/racial group |
15 | Donor re-entry following deferral for false reactive human immunodeficiency virus, hepatitis B virus and hepatitis C virus markers - Is it effective? |
16 | Patterns in unconfirmed syphilis repeat-reactive serology and potential confounders |
17 | Blood donor eligibility of sexual partners of successfully treated or spontaneously resolved hepatitis C infection |
18 | Congenital thrombotic thrombocytopenic purpura diagnosed in a 68-year-old patient |
19 | A Blood Donor Syncope/Faint Reaction Risk Assessment Tool |
20 | Proposal to revise Canadian Blood Services Blood Donor Criteria Related to Syncopal/Faint Reactions |
21 | Blindspots in targeted RHD genotyping: a review of perinatal cases sent for gene sequencing |
22 | Availability of Maternal Phenotype Matched RBC for Intra Uterine Transfusion |
23 | Establishing New Reference Interval for Total Protein and Immunoglobulin G Assay for Canadian Donor Population |
24 | Finding rare HLA-matched platelets for a high-risk stem cell transplant |
25 | Barriers and enablers to an inclusive and affirming experience for trans, nonbinary, Two-Spirit and other gender-diverse donors |
26 | Frequency of vasovagal reactions with large volume plasma donations in Canada |
27 | Liquid gold: A qualitative narrative study of immunoglobulin recipients |
28 | Donation experiences during the COVID-19 Pandemic |
29 | Optimal Packing Configuration for J82 Containers |
30 | Validation of a Cabinet X-ray Irradiator for On Demand Irradiation |
31 | Removal of the upper age limits for whole blood donation increase older donor participation over time |
32 | Epidemiology of and treatments for ligneous conjunctivitis: A literature review amid a surging demand for plasminogen eye drops prepared by Hema-Quebec |
33 | COVID-19 impact on massive hemorrhage protocol (MHP) performance across multiple hospital sites |
34 | Characterization of Ordering Practices and Testing Appropriateness of Cold Agglutinin Titres |
35 | Sample collection and handling errors association with the use of electronic positive patient identification devices (ePPID) |
36 | Evaluating the Variability in Use of Intravenous Albumin in Patients Undergoing Surgery for Cancer |
37 | An in-depth analysis of IVIG and SCIG utilization at three academic hospitals |
38 | Plasma Transfusion Practices: Informing a Knowledge Translation Strategy at Six Tertiary Care Hospitals |
39 | Pathogen reduced platelets at the Ottawa Hospital: One year's experience |
40 | Ethnic/Racial Diversity in Donors with Rare Red Cell Blood Types |
41 | Blood Antigen Genotyping Resolution for non-RH Blood Groups by Targeted DNA Sequencing: A 6-Year Retrospective Review |
42 | Transfusionist Education and Competency Assessment: Bloody Easy |
43 | Preparing for Provincial Bedside Audit of Blood Administration (BABA): Re-tooling the Audit Tool |
44 | The Operational Impact of Introducing Cold Stored Platelets |
45 | DATs for All Neonates? An Audit of Neonatal Direct Antiglobulin Testing (DAT) |
46 | Implementing sexual behavior-based screening: Staff training has never been more important |
47 | Auditing of product flow in a new prehospital transfusion program in a helicopter patient transfer service using a hybrid statistical and process mining methodology |
48 | Auditing using a hybrid conventional data analytical and process mining approach uncovers actionable patterns of red blood cell unit wastage in a health care region |
49 | Transparent Blood Inventory: Supporting planning and informed decision-making in blood shortage situations |
50 | Identifying opportunities and challenges in the use of an organizational website: results from a 2022 survey |
51 | Reflecting on British Columbia Red Blood Cell Inventory Management Perspectives and Experiences Identified from Technologists to Inform a Data-Driven Inventory Model |
52 | Transfusion Documentation: Where has the "Bridge" taken us over the last year |
53 | Pharmacists in Hemophilia Treatment Centres: A Trusted Partner in Patient Care |
54 | How Are Plasma Protein and Related Products Added to Canadian Blood Services Formulary? |
55 | Impact on Laboratory Operations by Extending On-analyzer Utilization Time of Reagent Red Blood Cells |
56 | Clinical Validation of the Transfusion Camp Knowledge Assessment Test |
57 | Health Canada Inspections from a Quality Perspective |
58 | Lessons learned from a hospital-based transfusion-practice education program |
59 | Characterizing the Impact of Donor Clinic Consolidation on Blood Product Quality |
60 | Validation of an Out-of-Lab Storage Container for Blood Product Access During Air Transport |
61 | Development of Ontario Regional Blood Coordinating Network (ORBCoN) Tech Assess in a Learning Management System |
62 | Massive Hemorrhage Protocol Quality Metrics: Blood Component Wastage at 11 hospital sites |
63 | Analysis of staffing shortages using root causes analysis data in the IQMH Discordance Finding Responses process during the period of pre-Pandemic vs Pandemic. |
64 | Reducing outpatient group and screen testing at a regional cancer centre: a quality improvement initiative. |
65 | Introduction of an MLA to Transfusion Medicine |
66 | Implementation of an Automated Decapping Instrument in a High-Volume Laboratory |
67 | Towards a Point-of-Care Method for the Detection of Ferritin in Blood Using a Surface Plasmon Resonance (SPR) Sensor |
68 | Flex Capacity Comparing Performances of Three Platelet Concentrate Production Processes to Meet Inventory Targets in Crisis Situation |
69 | Porcine Red Cell Concentrate Derived Perfusate has Improved Quality and Function Compared to Whole Blood During Ex Vivo Heart Perfusions |
70 | Hold on to Your Units: Quality of Red Cell Concentrates is only affected after Multiple Transient Warming Events |
71 | Evaluation of the Red Blood Cell Quality Obtained From Non-Anemic Donors With Signs of Iron Deficiency |
72 | Characterizing the impact of the RNA demethylase ALKBH5 on Hematopoietic Stem and Progenitor cells |
73 | Impact of Processing Time and Pathogen Inactivation on Apheresis PAS-E Platelets |
74 | Development of a storage solution for granulocyte concentrates used to treat life-threatening infections |
75 | ROS Inhibitor Rescues CD71+ RBC-Induced Reduction in CD14+ Monocyte Count in Human Monocyte Suspension Assay. |
76 | In vitro exposure of whole blood to a cannabinoid mixture impairs the quality of red blood cells and platelets |
77 | A Quality Conundrum: Investigating the Unintentional Warming of a Cryopreserved Red Cell Concentrate |
78 | Implementation of New Criteria for Performing MAIPA Test for FNAIT: A Retrospective Analysis |
79 | Improving the Droplet Freezing of Red Blood Cells |
80 | Comparable bacterial detection in apheresis platelet concentrates suspended in plasma or platelet additive solution E |
81 | Sebaceous sanctuary: Cutibacterium acnes displays heightened resistance to blood donor disinfection in the presence of skin sebum components |
82 | Inhibition of Coronavirus Infection by ABO Isoagglutinins |